Who owns NEUROPACE INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Neuropace with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neuropace stock

Who bought or sold NEUROPACE INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
KCK 5.6M $55M 0% Sep 2023
 View chart
OrbiMed Advisors 4.0M $41M 0% Dec 2023
 View chart
Soleus Capital Management 2.4M $25M -1% Dec 2023
 View chart
Morgan Stanley 2.4M $23M 2% Sep 2023
 View chart
Nantahala Capital Management 1.2M $12M -4% Dec 2023
 View chart
FMR 706k $6.9M -42% Sep 2023
 View chart
Kent Lake Capital 671k $6.9M 17% Dec 2023
 View chart
Vanguard Group 413k $4.3M 7% Dec 2023
 View chart
Millennium Management 172k $1.8M -6% Dec 2023
 View chart
Eudaimonia Asset Management 142k $1.4M 100% Sep 2023
 View chart
Geode Capital Management 110k $1.1M 54% Sep 2023
 View chart
Bridgeway Capital Management 60k $584k 0% Sep 2023
 View chart
BlackRock 60k $584k 66% Sep 2023
 View chart
Renaissance Technologies 44k $431k 156% Sep 2023
 View chart
Jane Street 37k $380k 100% Dec 2023
 View chart
Citigroup 35k $361k 1074% Dec 2023
 View chart
State Street Corporation 33k $324k 48% Sep 2023
 View chart
Bank of America Corporation 32k $329k 480% Dec 2023
 View chart
Balyasny Asset Management 27k $280k 100% Dec 2023
 View chart
683 Capital Management 25k $257k 100% Dec 2023
 View chart
Citadel Advisors 24k $248k 100% Dec 2023
 View chart
Northern Trust 22k $216k 38% Sep 2023
 View chart
Laurion Capital Management 21k $213k 100% Dec 2023
 View chart
Man Group 19k $199k 100% Dec 2023
 View chart
Townsquare Capital 16k $164k 100% Dec 2023
 View chart
Walleye Trading Advisors 14k $148k 100% Dec 2023
 View chart
Marshall Wace 14k $146k 100% Dec 2023
 View chart
Barclays 14k $147k 29% Dec 2023
 View chart
Cubist Systematic Strategies 11k $118k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 11k $117k 100% Dec 2023
 View chart
Virtu Financial 11k $111k 100% Dec 2023
 View chart
Financial Advocates Investment Management 10k $103k 0% Dec 2023
 View chart
Lazard Asset Management 3.9k $40k 100% Dec 2023
 View chart
Qube Research & Technologies 2.4k $23k 100% Sep 2023
 View chart
Point72 Asia 257.00 $2.7k 100% Dec 2023
 View chart
Advisor Group Holdings 233.00 $2.4k 100% Dec 2023
 View chart
Royal Bank of Canada 118.00 $1.0k 2850% Dec 2023
 View chart
Federated Investors 116.00 $1.2k -73% Dec 2023
 View chart
Wells Fargo & Company 81.00 $834.996600 9% Dec 2023
 View chart

Who sold out of Neuropace?

Fund or Company Name Date Sold Shares Held Valued At
Tower Research Capital Jun 2023 90.00 $404.001000